TABLE OF CONTENTS
Volume 26, Issue 49 (25 October 2007)
Review
Eighth International Mesothelioma Interest Group
M Carbone, S M Albelda, V C Broaddus, R M Flores, G Hillerdal, M-C Jaurand, K Kjaerheim, H I Pass, B Robinson and A Tsao
Oncogene 26: 6959-6967; advance online publication, May 14, 2007; doi:10.1038/sj.onc.1210515
Original Articles
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling
K Shtiegman, B S Kochupurakkal, Y Zwang, G Pines, A Starr, A Vexler, A Citri, M Katz, S Lavi, Y Ben-Basat, S Benjamin, S Corso, J Gan, R B Yosef, S Giordano and Y Yarden
Oncogene 26: 6968-6978; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210503
The transcription factor ZEB1 (
EF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
K Aigner, B Dampier, L Descovich, M Mikula, A Sultan, M Schreiber, W Mikulits, T Brabletz, D Strand, P Obrist, W Sommergruber, N Schweifer, A Wernitznig, H Beug, R Foisner and A Eger
Oncogene 26: 6979-6988; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210508
Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1
J Lin, T Sun, L Ji, W Deng, J Roth, J Minna and R Arlinghaus
Oncogene 26: 6989-6996; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210500
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer
J Bostner, M Ahnström Waltersson, T Fornander, L Skoog, B Nordenskjöld and O Stål
Oncogene 26: 6997-7005; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210506
Sensitization of pancreatic carcinoma cells for 
-irradiation-induced apoptosis by XIAP inhibition
S Giagkousiklidis, S H Vellanki, K-M Debatin and S Fulda
Oncogene 26: 7006-7016; advance online publication, April 30, 2007; doi:10.1038/sj.onc.1210502
Human p16, a novel transcriptional variant of p16INK4A, coexpresses with p16INK4A in cancer cells and inhibits cell-cycle progression
Y-C Lin, M B Diccianni, Y Kim, H-H Lin, C-H Lee, R-J Lin, S H Joo, J Li, T-J Chuang, A-S Yang, H-H Kuo, M-D Tsai and A L Yu
Oncogene 26: 7017-7027; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210507
Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells
D Berman-Golan and A Elson
Oncogene 26: 7028-7037; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210505
Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance
N Zantl, G Weirich, H Zall, B M Seiffert, S F Fischer, S Kirschnek, C Hartmann, R M Fritsch, B Gillissen, P T Daniel and G Häcker
Oncogene 26: 7038-7048; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210510
Overexpression of p101 activates PI3K signaling in T cells and contributes to cell survival
C Johnson, S J Marriott and L S Levy
Oncogene 26: 7049-7057; advance online publication, May 7, 2007; doi:10.1038/sj.onc.1210504
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy
S Glaros, G M Cirrincione, C Muchardt, C G Kleer, C W Michael and D Reisman
Oncogene 26: 7058-7066; advance online publication, June 4, 2007; doi:10.1038/sj.onc.1210514
